1
|
Tsui R, Chow V, Wong C, Liu T, Luk A, Wu M, Fung CP, Chow G, Leung P, Sham R, Chan M. P29-A135 Impact of COVID-19 on corneal donation and transplantation in Hong Kong. BMJ Open Ophthalmol 2023; 8:A12. [PMID: 37604537 DOI: 10.1136/bmjophth-2023-eeba.28] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/23/2023] Open
Abstract
PURPOSE With many health and policy issues arising from COVID-19, the Hospital Authority Eye Bank of Hong Kong encountered challenges related to ocular donor suitability and availability. This review aims to analyse the impact of a global pandemic on corneal donation and transplantation in 2020 and 2021, compared to the pre-COVID period in 2019. METHODS This cohort study evaluated data collected from the Hospital Authority Eye Bank from January 2019 to December 2021. The number of corneas harvested, including voluntary donations initiated by the deceased's relatives and approached cases by Eye Donation Coordinators, tissue distributed, transplanted and disposed, the reason for disposal as well as the usage of the transplanted corneas in 2020 and 2021 were compared to the pre-COVID period of 2019. RESULTS The number of corneas harvested dropped by 17.6% in 2020 compared to the pre-COVID period of 2019, and rose almost back to baseline in 2021. However, despite having near-normal number of harvested corneas in 2021, the number of corneal transplants using fresh corneas were still reduced by 30% in 2020 and 27% 2021. The observation can be explained by the seven-fold increment in disposal due to suboptimal quality from a cancer donor in 2021. The proportion of corneas used for optical, therapeutic and tectonic purposes remained stable throughout the three years. CONCLUSION COVID-19 yielded brief periods of service interruption and reduced number of eligible donors, leading to a noticeable rise in solicitation from cancer donors in 2021. The pandemic resulted in a longer corneal transplant waiting time. Nevertheless, The proportion of different corneal transplantation remained stable, with even the development in new techniques such as Descemet's Membrane Endothelial Keratoplasty and enhancement in services such as provision of ultra-fresh Keratolimbal allografts despite the limitations in the COVID-19 era.
Collapse
Affiliation(s)
- Rachel Tsui
- Hong Kong Eye Hospital, Hong Kong S.A.R., China
| | - Vanissa Chow
- Hong Kong Eye Hospital, Hong Kong S.A.R., China
- Hospital Authority Eye Bank, Hong Kong S.A.R., China
| | | | - Terry Liu
- Hospital Authority Eye Bank, Hong Kong S.A.R., China
| | - Amanda Luk
- Hospital Authority Eye Bank, Hong Kong S.A.R., China
| | - Maggie Wu
- Hospital Authority Eye Bank, Hong Kong S.A.R., China
| | - Chi-Pui Fung
- Hospital Authority Eye Bank, Hong Kong S.A.R., China
| | - Galen Chow
- Hospital Authority Eye Bank, Hong Kong S.A.R., China
| | - Peggy Leung
- Hospital Authority Eye Bank, Hong Kong S.A.R., China
| | - Rianna Sham
- Hospital Authority Eye Bank, Hong Kong S.A.R., China
| | - Moni Chan
- Hospital Authority Eye Bank, Hong Kong S.A.R., China
| |
Collapse
|
2
|
Mitchell S, Tsui R, Tan ZC, Pack A, Hoffmann A. The NF-κB multidimer system model: A knowledge base to explore diverse biological contexts. Sci Signal 2023; 16:eabo2838. [PMID: 36917644 PMCID: PMC10195159 DOI: 10.1126/scisignal.abo2838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2022] [Accepted: 02/22/2023] [Indexed: 03/16/2023]
Abstract
The nuclear factor κB (NF-κB) system is critical for various biological functions in numerous cell types, including the inflammatory response, cell proliferation, survival, differentiation, and pathogenic responses. Each cell type is characterized by a subset of 15 NF-κB dimers whose activity is regulated in a stimulus-responsive manner. Numerous studies have produced different mathematical models that account for cell type-specific NF-κB activities. However, whereas the concentrations or abundances of NF-κB subunits may differ between cell types, the biochemical interactions that constitute the NF-κB signaling system do not. Here, we synthesized a consensus mathematical model of the NF-κB multidimer system, which could account for the cell type-specific repertoires of NF-κB dimers and their cell type-specific activation and cross-talk. Our review demonstrates that these distinct cell type-specific properties of NF-κB signaling can be explained largely as emergent effects of the cell type-specific expression of NF-κB monomers. The consensus systems model represents a knowledge base that may be used to gain insights into the control and function of NF-κB in diverse physiological and pathological scenarios and that describes a path for generating similar regulatory knowledge bases for other pleiotropic signaling systems.
Collapse
Affiliation(s)
- Simon Mitchell
- Signaling Systems Laboratory, Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA 90095, USA
- Institute for Quantitative and Computational Biosciences, UCLA, Los Angeles, CA 90095, USA
- Brighton and Sussex Medical School, Department of Clinical and Experimental Medicine, University of Sussex, Falmer, East Sussex, BN1 9PX, UK
| | - Rachel Tsui
- Signaling Systems Laboratory, Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA 90095, USA
| | - Zhixin Cyrillus Tan
- Institute for Quantitative and Computational Biosciences, UCLA, Los Angeles, CA 90095, USA
| | - Arran Pack
- Brighton and Sussex Medical School, Department of Clinical and Experimental Medicine, University of Sussex, Falmer, East Sussex, BN1 9PX, UK
| | - Alexander Hoffmann
- Signaling Systems Laboratory, Department of Microbiology, Immunology, and Molecular Genetics, UCLA, Los Angeles, CA 90095, USA
- Institute for Quantitative and Computational Biosciences, UCLA, Los Angeles, CA 90095, USA
| |
Collapse
|
3
|
Ramsay I, Sharrocks K, Warne B, Sithole N, Ravji P, Bousfield R, Jones N, Leong CE, Suliman M, Tsui R, Toleman MS, Moody C, Smith R, Whitehorn J, Gouliouris T, Penciu F, Hofling C, Cunningham C, Enoch DA, Moore E. Investigation of healthcare-associated SARS-CoV-2 infection: Learning outcomes from an investigative process in the initial phase of the pandemic. J Infect Prev 2022; 23:197-205. [PMID: 36003131 PMCID: PMC9117956 DOI: 10.1177/17571774221092553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2021] [Accepted: 02/21/2022] [Indexed: 11/17/2022] Open
Abstract
Background Healthcare-associated (HCA) SARS-CoV-2 infection is a significant contributor
to the spread of the 2020 pandemic. Timely review of HCA cases is essential
to identify learning to inform infection prevention and control (IPC)
policies and organisational response. Aim To identify key areas for improvement through rapid investigation of HCA
SARS-CoV-2 cases and to implement change. Methods Cases were identified based on date of first positive SARS-CoV-2 PCR sample
in relation to date of hospital admission. Cases were reviewed using a
structured gap analysis tool to identify key learning points. These were
discussed in weekly multidisciplinary meetings to gain consensus on learning
outcomes, level of harm incurred by the patient and required actions.
Learning was then promptly fed back to individual teams and the
organisation. Findings Of the 489 SARS-CoV-2 cases admitted between 10th March and
23rd June 2020, 114 suspected HCA cases (23.3%) were
reviewed; 58/489 (11.8%) were ultimately deemed to be HCA. Five themes were
identified: individual patient vulnerability, communication, IPC
implementation, policy issues and organisational response. Adaptations to
policies based on these reviews were completed within the course of the
initial phase of the pandemic. Conclusion This approach enabled timely learning and implementation of control measures
and policy development.
Collapse
Affiliation(s)
- Isobel Ramsay
- Clinical Microbiology & Public Health Laboratory, Cambridge, UK
- Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - Katherine Sharrocks
- Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - Ben Warne
- Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - Nyarie Sithole
- Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - Pooja Ravji
- Clinical Microbiology & Public Health Laboratory, Cambridge, UK
- Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - Rachel Bousfield
- Clinical Microbiology & Public Health Laboratory, Cambridge, UK
- Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - Nick Jones
- Clinical Microbiology & Public Health Laboratory, Cambridge, UK
- Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - Clare E Leong
- Clinical Microbiology & Public Health Laboratory, Cambridge, UK
- Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - Mohamed Suliman
- Clinical Microbiology & Public Health Laboratory, Cambridge, UK
- Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - Rachel Tsui
- Clinical Microbiology & Public Health Laboratory, Cambridge, UK
| | | | - Christine Moody
- Clinical Microbiology & Public Health Laboratory, Cambridge, UK
| | - Richard Smith
- Clinical Microbiology & Public Health Laboratory, Cambridge, UK
| | - James Whitehorn
- Clinical Microbiology & Public Health Laboratory, Cambridge, UK
- Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - Theodore Gouliouris
- Clinical Microbiology & Public Health Laboratory, Cambridge, UK
- Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | | | - Christian Hofling
- Infectious Diseases, Universidade Estadual de Campinas, Campinas, Brazil
| | - Chris Cunningham
- Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| | - David A Enoch
- Clinical Microbiology & Public Health Laboratory, Cambridge, UK
| | - Elinor Moore
- Infectious Diseases, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
| |
Collapse
|
4
|
Errington TM, Denis A, Allison AB, Araiza R, Aza-Blanc P, Bower LR, Campos J, Chu H, Denson S, Donham C, Harr K, Haven B, Iorns E, Kwok J, McDonald E, Pelech S, Perfito N, Pike A, Sampey D, Settles M, Scott DA, Sharma V, Tolentino T, Trinh A, Tsui R, Willis B, Wood J, Young L. Experiments from unfinished Registered Reports in the Reproducibility Project: Cancer Biology. eLife 2021; 10:73430. [PMID: 34874009 PMCID: PMC8651290 DOI: 10.7554/elife.73430] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2021] [Accepted: 11/14/2021] [Indexed: 12/16/2022] Open
Abstract
As part of the Reproducibility Project: Cancer Biology, we published Registered Reports that described how we intended to replicate selected experiments from 29 high-impact preclinical cancer biology papers published between 2010 and 2012. Replication experiments were completed and Replication Studies reporting the results were submitted for 18 papers, of which 17 were accepted and published by eLife with the rejected paper posted as a preprint. Here, we report the status and outcomes obtained for the remaining 11 papers. Four papers initiated experimental work but were stopped without any experimental outcomes. Two papers resulted in incomplete outcomes due to unanticipated challenges when conducting the experiments. For the remaining five papers only some of the experiments were completed with the other experiments incomplete due to mundane technical or unanticipated methodological challenges. The experiments from these papers, along with the other experiments attempted as part of the Reproducibility Project: Cancer Biology, provides evidence about the challenges of repeating preclinical cancer biology experiments and the replicability of the completed experiments.
Collapse
Affiliation(s)
| | | | - Anne B Allison
- Piedmont Virginia Community College, Charlottesville, United States
| | - Renee Araiza
- University of California, Davis, Davis, United States
| | | | | | | | - Heidi Chu
- Applied Biological Materials, Richmond, Canada
| | - Sarah Denson
- University of California, Davis, Davis, United States
| | | | - Kaitlyn Harr
- University of Virginia, Charlottesville, United States
| | | | | | - Jennie Kwok
- Applied Biological Materials, Richmond, Canada
| | - Elysia McDonald
- Drexel University College of Medicine, Philadelphia, United States
| | - Steven Pelech
- Kinexus Bioinformatics, Vancouver, Canada.,University of British Columbia, Vancouver, United States
| | | | - Amanda Pike
- Applied Biological Materials, Richmond, Canada
| | | | | | - David A Scott
- Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States
| | | | | | | | | | | | - Joshua Wood
- University of California, Davis, Davis, United States
| | - Lisa Young
- Applied Biological Materials, Richmond, Canada
| |
Collapse
|
5
|
Shan X, Danet-Desnoyers G, Aird F, Kandela I, Tsui R, Perfito N, Iorns E. Replication study: androgen receptor splice variants determine taxane sensitivity in prostate cancer. PeerJ 2018; 6:e4661. [PMID: 29682426 PMCID: PMC5907780 DOI: 10.7717/peerj.4661] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2017] [Accepted: 04/02/2018] [Indexed: 11/29/2022] Open
Abstract
In 2015, as part of the Prostate Cancer Foundation–Movember Foundation Reproducibility Initiative, we published a Registered Report (Shan et al., 2015) that described how we intended to replicate selected experiments from the paper “Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer” (Thadani-Mulero et al., 2014). Here we report the results of those experiments. Growth of tumor xenografts from two prostate cancer xenograft lines, LuCaP 86.2, which expresses wild-type androgen receptor (AR) and AR variant 567, and LuCaP 23.1, which expresses wild-type AR and AR variant 7, were not affected by docetaxel treatment. The LuCaP 23.1 tumor xenografts grew slower than in the original study. This result is different from the original study, which reported significant reduction of tumor growth in the LuCaP 86.2. Furthermore, we were unable to detect ARv7 in the LuCaP 23.1, although we used the antibody as stated in the original study and ensured that it was detecting ARv7 via a known positive control (22rv1, Hörnberg et al., 2011). Finally, we report a meta-analysis of the result.
Collapse
Affiliation(s)
- Xiaochuan Shan
- Stem Cell and Xenograft Core, Perelman School of Medicine, Philadelphia, PA, USA
| | | | - Fraser Aird
- Developmental Therapeutics Core, Northwestern University, Evanston, IL, USA
| | - Irawati Kandela
- Developmental Therapeutics Core, Northwestern University, Evanston, IL, USA
| | - Rachel Tsui
- Science Exchange and The Prostate Cancer Foundation-Movember Foundation Reproducibility Initiative, Palo Alto, CA, USA
| | - Nicole Perfito
- Science Exchange and The Prostate Cancer Foundation-Movember Foundation Reproducibility Initiative, Palo Alto, CA, USA
| | - Elizabeth Iorns
- Science Exchange and The Prostate Cancer Foundation-Movember Foundation Reproducibility Initiative, Palo Alto, CA, USA
| |
Collapse
|
6
|
Tsui R, Kearns JD, Lynch C, Vu D, Ngo K, Basak S, Ghosh G, Hoffmann A. IκBβ enhances the generation of the low-affinity NFκB/RelA homodimer. Nat Commun 2015; 6:7068. [PMID: 25946967 PMCID: PMC4425231 DOI: 10.1038/ncomms8068] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2014] [Accepted: 03/27/2015] [Indexed: 01/21/2023] Open
Abstract
The NFκB family of dimeric transcription factors regulate inflammatory and immune responses. While the dynamic control of NFκB dimer activity via the IκB-NFκB signalling module is well understood, there is little information on how specific dimer repertoires are generated from Rel family polypeptides. Here we report the iterative construction-guided by in vitro and in vivo experimentation-of a mathematical model of the Rel-NFκB generation module. Our study reveals that IκBβ has essential functions within the Rel-NFκB generation module, specifically for the RelA:RelA homodimer, which controls a subset of NFκB target genes. Our findings revise the current dogma of the three classical, functionally related IκB proteins by distinguishing between a positive 'licensing' factor (IκBβ) that contributes to determining the available NFκB dimer repertoire in a cell's steady state, and negative feedback regulators (IκBα and -ɛ) that determine the duration and dynamics of the cellular response to an inflammatory stimulus.
Collapse
Affiliation(s)
- Rachel Tsui
- Signaling Systems Laboratory, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
- The San Diego Center for Systems Biology, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
- Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
| | - Jeffrey D. Kearns
- Signaling Systems Laboratory, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
- Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
| | - Candace Lynch
- Signaling Systems Laboratory, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
- Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
| | - Don Vu
- Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
| | - Kim Ngo
- Signaling Systems Laboratory, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
- The San Diego Center for Systems Biology, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
- Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
| | - Soumen Basak
- Signaling Systems Laboratory, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
- Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
| | - Gourisankar Ghosh
- Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
| | - Alexander Hoffmann
- Signaling Systems Laboratory, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
- The San Diego Center for Systems Biology, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
- Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375
- Department of Microbiology, Immunology and Molecular Genetics (MIMG), and the Institute for Quantitative and Computational Biosciences (QCB), University of California, Los Angeles, CA 90095
| |
Collapse
|
7
|
Tsui R, Lopez B, Gunda S. SP241OPTIMISING THE PERFORMANCE OF THE NATIONAL AKI WARNING ALGORITHM ACROSS A MULTI-LIMS NETWORK. Nephrol Dial Transplant 2015. [DOI: 10.1093/ndt/gfv190.53] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
8
|
Almaden JV, Tsui R, Liu YC, Birnbaum H, Shokhirev MN, Ngo KA, Davis-Turak JC, Otero D, Basak S, Rickert RC, Hoffmann A. A pathway switch directs BAFF signaling to distinct NFκB transcription factors in maturing and proliferating B cells. Cell Rep 2014; 9:2098-111. [PMID: 25497099 PMCID: PMC4889572 DOI: 10.1016/j.celrep.2014.11.024] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2014] [Revised: 11/04/2014] [Accepted: 11/17/2014] [Indexed: 11/27/2022] Open
Abstract
BAFF, an activator of the noncanonical NFκB pathway, provides critical survival signals during B cell maturation and contributes to B cell proliferation. We found that the NFκB family member RelB is required ex vivo for B cell maturation, but cRel is required for proliferation. Combined molecular network modeling and experimentation revealed Nfkb2 p100 as a pathway switch; at moderate p100 synthesis rates in maturing B cells, BAFF fully utilizes p100 to generate the RelB:p52 dimer, whereas at high synthesis rates, p100 assembles into multimeric IκBsome complexes, which BAFF neutralizes in order to potentiate cRel activity and B cell expansion. Indeed, moderation of p100 expression or disruption of IκBsome assembly circumvented the BAFF requirement for full B cell expansion. Our studies emphasize the importance of p100 in determining distinct NFκB network states during B cell biology, which causes BAFF to have context-dependent functional consequences.
Collapse
Affiliation(s)
- Jonathan V Almaden
- Signaling Systems Laboratory and San Diego Center for Systems Biology, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA
| | - Rachel Tsui
- Signaling Systems Laboratory and San Diego Center for Systems Biology, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA
| | - Yi C Liu
- Department of Microbiology, Immunology, and Molecular Genetics and Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, Los Angeles, CA 90025, USA
| | - Harry Birnbaum
- Signaling Systems Laboratory and San Diego Center for Systems Biology, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA; Department of Microbiology, Immunology, and Molecular Genetics and Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, Los Angeles, CA 90025, USA
| | - Maxim N Shokhirev
- Signaling Systems Laboratory and San Diego Center for Systems Biology, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA
| | - Kim A Ngo
- Signaling Systems Laboratory and San Diego Center for Systems Biology, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA; Department of Microbiology, Immunology, and Molecular Genetics and Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, Los Angeles, CA 90025, USA
| | - Jeremy C Davis-Turak
- Signaling Systems Laboratory and San Diego Center for Systems Biology, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA
| | - Dennis Otero
- Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA
| | - Soumen Basak
- Systems Immunology Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, India
| | - Robert C Rickert
- Program on Inflammatory Disease Research, Infectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA
| | - Alexander Hoffmann
- Signaling Systems Laboratory and San Diego Center for Systems Biology, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA; Department of Microbiology, Immunology, and Molecular Genetics and Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, Los Angeles, CA 90025, USA.
| |
Collapse
|
9
|
Alves BN, Tsui R, Almaden J, Shokhirev MN, Davis-Turak J, Fujimoto J, Birnbaum H, Ponomarenko J, Hoffmann A. IκBε is a key regulator of B cell expansion by providing negative feedback on cRel and RelA in a stimulus-specific manner. J Immunol 2014; 192:3121-32. [PMID: 24591377 DOI: 10.4049/jimmunol.1302351] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
The transcription factor NF-κB is a regulator of inflammatory and adaptive immune responses, yet only IκBα was shown to limit NF-κB activation and inflammatory responses. We investigated another negative feedback regulator, IκBε, in the regulation of B cell proliferation and survival. Loss of IκBε resulted in increased B cell proliferation and survival in response to both antigenic and innate stimulation. NF-κB activity was elevated during late-phase activation, but the dimer composition was stimulus specific. In response to IgM, cRel dimers were elevated in IκBε-deficient cells, yet in response to LPS, RelA dimers also were elevated. The corresponding dimer-specific sequences were found in the promoters of hyperactivated genes. Using a mathematical model of the NF-κB-signaling system in B cells, we demonstrated that kinetic considerations of IκB kinase-signaling input and IκBε's interactions with RelA- and cRel-specific dimers could account for this stimulus specificity. cRel is known to be the key regulator of B cell expansion. We found that the RelA-specific phenotype in LPS-stimulated cells was physiologically relevant: unbiased transcriptome profiling revealed that the inflammatory cytokine IL-6 was hyperactivated in IκBε(-/-) B cells. When IL-6R was blocked, LPS-responsive IκBε(-/-) B cell proliferation was reduced to near wild-type levels. Our results provide novel evidence for a critical role for immune-response functions of IκBε in B cells; it regulates proliferative capacity via at least two mechanisms involving cRel- and RelA-containing NF-κB dimers. This study illustrates the importance of kinetic considerations in understanding the functional specificity of negative-feedback regulators.
Collapse
Affiliation(s)
- Bryce N Alves
- Signaling Systems Laboratory, Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093
| | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Said JM, Tsui R, Borg AJ, Higgins JR, Moses EK, Walker SP, Monagle PT, Brennecke SP. The PAI-1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women. J Thromb Haemost 2012; 10:881-6. [PMID: 22432640 DOI: 10.1111/j.1538-7836.2012.04700.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
BACKGROUND Plasminogen activator inhibitor type 1 (PAI-1) is an important regulator of fibrinolysis. A common deletion polymorphism that results in a sequence of 4G instead of 5G in the promoter region of the gene is associated with a small increase in the risk of venous thromboembolism. Its potential association with adverse pregnancy events remains controversial. OBJECTIVE We aimed to assess the impact of the 4G PAI-1 polymorphism on pregnancy outcomes in women who had no prior history of adverse pregnancy outcomes or personal or family history of venous thromboembolism. PATIENTS/METHODS This study represents a secondary investigation of a prior prospective cohort study investigating the association between inherited thrombophilias and adverse pregnancy events in Australian women. Healthy nulliparous women were recruited to this study prior to 22 weeks gestation. Genotyping for the 4G/5G PAI-1 gene was performed using Taqman assays in an ABI prism 7700 Sequencer several years after the pregnancy was completed. Pregnancy outcome data were extracted from the medical record. The primary outcome was a composite comprising development of severe pre-eclampsia, fetal growth restriction, major placental abruption, stillbirth or neonatal death. RESULTS Pregnancy outcome data were available in 1733 women who were successfully genotyped for this polymorphism. The primary composite outcome was experienced by 139 women (8% of the cohort). Four hundred and fifty-nine women (26.5%) were homozygous for the 4G deletion polymorphism, while 890 (51.4%) were heterozygous. Neither homozygosity nor heterozygosity for the PAI-1 4G polymorphism was associated with the primary composite outcome (homozygous OR = 1.30, 95% CI = 0.81-2.09, P = 0.28, heterozygous OR = 0.84, 95% CI = 0.53-1.31, P = 0.44) or with the individual pregnancy complications. CONCLUSION The PAI-1 4G polymorphism is not associated with an increase in the risk of serious adverse pregnancy events in asymptomatic nulliparous women.
Collapse
Affiliation(s)
- J M Said
- Department of Perinatal Medicine, The Royal Women's Hospital, Parkville, Australia.
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Boussaad S, Xu BQ, Nagahara LA, Amlani I, Schmickler W, Tsui R, Tao NJ. Discrete tunneling current fluctuations in metal–water–metal tunnel junctions. J Chem Phys 2003. [DOI: 10.1063/1.1566933] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
12
|
Affiliation(s)
- H He
- Department of Physics, Florida International University, Miami, Florida 33199, USA
| | | | | | | | | | | |
Collapse
|
13
|
Abstract
We have studied the adsorption of mercaptopropionic acid, 2,2'-bipyridine, and dopamine onto electrochemically fabricated Cu nanowires. The nanowires are atomically thin with conductance quantized near integer multiples of 2e(2)/h. Upon molecular adsorption, the quantized conductance decreases to a fractional value, due to the scattering of the conduction electrons by the adsorbates. The decrease is as high as 50% for the thinnest nanowires whose conductance is at the lowest quantum step, and smaller for thicker nanowires with conductance at higher quantum steps. The adsorbate-induced conductance changes depend on the binding strengths of the molecules to the nanowires, which are in the order of mercaptopropionic acid, 2,2'-bipyridine, and dopamine, from strongest to weakest. The sensitive dependence of the quantized conductance on molecular adsorption may be used for molecular detection.
Collapse
Affiliation(s)
- A Bogozi
- Department of Physics, Florida International University, Miami, Florida 33199, USA
| | | | | | | | | | | | | | | |
Collapse
|
14
|
|